Breaking AI & Tech News Analyzed

The LeadThe Guardian has released its ultimate summer TV guide, highlighting a range of new shows to look out for.The Summer TV LineupThe guide includes House of the Dragon, which is set to return with James Norton as a newly announced co-star. The show promises to deliver scale and spectacle.Other Notable ShowsThe Bear: Ayo Edebiri stars in this show, which seems to be back to its best after a few struggling seasons.Life, Larry and the Pursuit of Unhappiness: A historical sketch show starring Larry David, produced by the Obamas.Would You Rather: Decide to Survive: A comedy gameshow hosted by Romesh Ranganathan.Elle: A prequel to the Legally Blonde films, written by Laura Kittrell.Silo: Rebecca Ferguson stars in this Apple TV show, which promises to uncover dark truths.Little House on the Prairie: A new adaptation of the classic series.The Data AnalysisThe guide provides insights into release dates and streaming platforms:House of the Dragon: Sky Atlantic/Now/HBO Max, 22 June.The Bear: Disney+, 26 June.Life, Larry and the Pursuit of Unhappiness: HBO Max, 27 June.Would You Rather: Decide to Survive: Prime Video, 26 June.Elle: Prime Video, 1 July.Silo: Apple TV, 3 July.The Impact AnalysisThis summer TV guide caters to a wide range of audiences with diverse interests, from fantasy and comedy to historical sketches and prequel series.The PredictionThese shows are expected to attract significant attention and viewership, with some already generating buzz on social media and among fans.

The Remix of a Classic Words, words, words. Can Hamlet retain its tragic force without using most of them? This hour-long dance-theatre remix by the late South African choreographer Dada Masilo preserves few speeches and its opening is not auspicious, crashing straight into “To be, or not to be” shorn of context and characterisation. The Dance of Ophelia and Hamlet There follows, as is customary, a meeting between the prince and Ophelia, but Masilo replaces the usual cruel encounter with stolen moments amid a ceremony, as if they are meeting anew like Romeo and Juliet at the Capulet ball. Matching each other’s movements, amid clapped hands, thrusting shoulders and rippling chests, they grow closer with a hint of tango footwork. From this flashback, Masilo practically fast-forwards their choreography with a sense of doom. The Emotional Depth of Gertrude Letting the pair share a tender duet reinforces their romance but also heightens the violence of the nunnery scene where they are traditionally first seen together. Masilo adds another new scene to show Gertrude’s despair upon receiving news of Old Hamlet’s death rather than introducing her as sanguinely remarried to his brother. We see her seek strength amid grief, supported by courtiers whose pulsing, grounded movement is a message of persistence. This is dancing felt in the gut. The Impact of Movement and Music Wooed offstage, Gertrude returns for a convivial ceremony where a young couple are ticked off for getting too raunchy on the dancefloor. Movement styles across generations and cultures are blended by Masilo, who drew attention for remoulding ballet’s classics. Her ensemble is often an industrious force, driven by relentless percussion, as each scene breaks like a wave against Thuthuka Sibisi’s compositions. The Tragic Conclusion The latter stages lose focus but the choreography’s omnipresent sense of returning to the earth foreshadows a climax where all are struck down by the kingdom’s collective sickness, stressed by the lighting of Suzette le Sueur (who also provides some of the elegant costumes). It’s a collection of often piercing scenes that never quite establish full collective power – a tragedy out of joint. At Sadler’s Wells, London, until 26 May

The Crisis Facing Young People in the UK Alan Milburn's report paints a grim picture of the lives and chances of young people in the UK. The diagnosis is dire, with over 1 million young people not in work, education, or training (Neets), and this number expected to rise to 1.25 million without radical change. The Extent of the Problem Milburn's report reveals a catastrophic failure in the support systems for young people. There has been institutional neglect, loss of youth and careers services, and chaotic communication between dislocated silos. The result is a 'moral crisis' that requires a 'big idea' and a 'system reset'. The report highlights that: 1.6 million first-rung jobs have vanished in the past 20 years. There has been a 35% fall in apprenticeship starts in the past decade. 60% of Neets have never had a job before. The Impact on Young People's Lives The report captures the misery of young people applying for jobs, facing rejection, and struggling with mental health issues. Many young people are eager to work or pursue apprenticeships, but face significant barriers. For example: 84% of those surveyed wanted to work or do an apprenticeship. 19% wanted to enter education or training. 15% have degrees. 30% have five good GCSEs or equivalent. The Way Forward Milburn's report calls for a comprehensive overhaul of the systems failing young people. He criticizes the current education system, which prioritizes exam results over outcomes and destinations. He also highlights the need for better support for young people with troubled families or poor mental health. The report's recommendations are expected to be released in a future publication, just before the Labour conference. A Call to Action for Labour The report presents a challenge to the Labour party to take action and address the crisis facing young people. As Labour strives for renewed purpose, Milburn's report provides a roadmap for change. The government is urged to ignore previous interventions, such as Tony Blair's recent essay, and instead focus on implementing the recommendations outlined in Milburn's report.

The Soros Foundation's Major US InvestmentFor decades, the Open Society Foundations have worked to advance justice and human rights in Africa, the Middle East and trouble spots around the world. But the OSF's latest major investment is aimed at a crisis closer to home. On Tuesday, the organisation, founded by the billionaire philanthropist George Soros and headquartered in New York, announced a $300m spend aimed at boosting economic security and defending civil liberties in the US.Addressing America's Dual CrisisThe drastic commitment comes 16 months into Donald Trump's second term as president, with millions of Americans suffering an affordability crisis and activists warning of an extraordinary attack on the rule of law. "We certainly believe that civil society is essential and must stay on the playing field," said Laleh Ispahani, managing director for the US at the OSF. "We've had experience in other countries, unfortunately, where civil society has been targeted by autocratic administrations. It does matter that we still are funding in most parts of the world and are very much in communication with one another as things are happening in the US."The Soros Legacy and Political BacklashSoros has given more than $32bn of his personal fortune to causes around the world. He is also a longtime Democratic donor and favorite bogeyman for the right. The attacks frequently rely on antisemitic tropes, framing Soros – a Jewish survivor of the Nazi occupation in Hungary – as a "globalist" puppet master. Asked whether the foundation was prepared for an inevitable backlash accusing Soros of meddling in US democracy, Ispahani sounded unfazed, saying: "We fully expect that. We wouldn't expect anything less. But we also won't be intimidated into silence."An Integrated Approach to Rights and EconomyFor decades, reformers have often operated in silos, focusing their energies either squarely on democratic rights or exclusively on economic justice. OSF's new initiative is designed to break down those barriers. "What's new and different and perhaps most distinct about this is that it's a unified and focused effort," Ispahani explained. "We want to fund this integrated strategy to improve our democracy by both modernising our rights and freedoms and reforming our economy as things that are two sides of the same coin, because when one suffers, inevitably the other does, too."The Erosion of Civil Rights ProtectionsThe urgency is driven by what the OSF perceives as an alarming reversal of fundamental protections, spearheaded by a rightwing majority on the supreme court. "It's pretty clear to us that today these rights are being rolled back, including the right to protest, civil rights and voting rights, with the supreme court's recent decisions eviscerating very key protections of the civil rights era," Ispahani said. "We had the supreme court putting a nail in the coffin of what was a very widely respected Voting Rights Act with its recent decision in the Louisiana v Callais case, so we're back to this pre-60s moment in the world."Modernizing the Civil Rights ParadigmTo combat this, the OSF is advocating for an expansion of the civil rights paradigm to meet modern threats, from securing the right to elect representatives of the voter's choice to combating new forms of discrimination in algorithmic and technology-driven bias. The OSF has already committed $20m for this year to help organisations on the frontlines with strategic litigation, non-profit sector defence and efforts to track government corruption. Among them are the Roosevelt Institute, the Groundwork Collaborative thinktank, the National Women's Law Center, and state-level groups such as Living United for Change in Arizona.Economic Inequality in AmericaThe other central pillar of the $300m investment is economic security. Even in the wealthiest country in the world, the child poverty rate is 14.3%, estimated to affect about 10.4 million children. The top 20% of households currently capture more than half of all national income. Ispahani argues the current system is failing. "Why not have moral and material rights that resonate across constituencies?" she said. "The right to a good job with fair wages and safe working conditions isn't controversial. The right to stable and affordable housing is likely very popular. The right to accessible and affordable childcare is likely also very popular."The Future of American DemocracyThe Open Society Foundations' substantial investment represents a significant commitment to preserving democratic values in the United States during a period of political polarization and economic uncertainty. By linking civil liberties with economic security, the foundation aims to create a more comprehensive approach to addressing America's challenges. As Ispahani stated, "We think our work has never mattered more. It matters most in places when democracy is under attack, when rights are being rolled back and peaceful dissent is being criminalized."

The Breakthrough in Addiction Treatment Results from a new clinical trial published in JAMA Network Open this month show that a single dose of psilocybin could be an effective treatment for cocaine addiction. The study found that 19 participants who received psilocybin were more likely to abstain from cocaine than 17 participants who received a placebo of diphenhydramine, a common antihistamine. Participants in both groups worked with therapists to process their experiences, highlighting the importance of the therapeutic context alongside the medication. The Urgent Need for Cocaine Addiction Treatments Dr. Peter Hendricks, a behavioral health professor at the University of Alabama at Birmingham and lead author of the study, emphasized the critical need for effective treatments. Currently, there are no FDA-approved medications for addiction to cocaine or other stimulants like methamphetamine. Overdoses involving stimulants are killing more Americans, and according to the latest UN global drug report, cocaine deaths are rising globally as cocaine production reaches an all-time high. Understanding the Mechanism Experts believe psilocybin works by increasing neuroplasticity and psychological plasticity – the ability to change thinking and behavior. Addictions inherently involve resistance to changing rigid, impulsive behaviors, which psychedelics may help overcome. Unlike traditional addiction medications that target the same neurochemical systems as the substance itself, psilocybin produces a profound altered state of consciousness within a structured psychotherapy context. It acts more like a catalyst within a therapeutic process rather than a maintenance medication. Addressing Cocaine Withdrawal Symptoms Cocaine withdrawal symptoms are primarily psychological rather than physically painful, including bad dreams, agitation, depression, and cravings. This psychological nature may make psilocybin particularly effective for cocaine addiction, as it can facilitate shifts in perspective and self-compassion that help people change their behavior. The therapeutic framework allows individuals to process their experiences and develop new insights about their addiction patterns, potentially breaking the cycle of craving and use. Diverse Clinical Trial Participation This study is notable as the first psychedelic clinical trial to include a majority of Black participants. While many spiritual rituals involving psychedelics originated in Indigenous societies in Latin America and Africa, US psychedelic culture today is often associated with Silicon Valley and elite, white personalities. Dr. Hendricks specifically recruited participants who were dependent on cocaine and wanted to stop, rather than advertising for psychedelic enthusiasts. This approach likely reduced the "expectation effect" and produced more generalizable results. Future Research Directions A critical commentary published alongside the study noted that the results might not be generally applicable because the study excluded people with comorbid depression and anxiety. However, experts point out that psilocybin shows promise for treating both conditions. The success of this trial is a clear indication that psilocybin for cocaine use disorder is a promising treatment that should proceed to larger-scale clinical trials. As research continues, the medical community may gain more insight into how psychedelics can be integrated into addiction treatment protocols.

Trump’s Public Endorsement of Psychedelic TherapiesIn a recent Guardian podcast, Donald Trump signaled support for scientific studies into psychedelic compounds, asking, “Can I have some, please?” while framing the conversation as a potential public‑health breakthrough.Funding Landscape and Recent Regulatory Milestones2023: The U.S. Food and Drug Administration granted breakthrough‑therapy designation to psilocybin for treatment‑resistant depression.2024: The National Institute on Drug Abuse allocated $150 million to clinical trials of MDMA‑assisted psychotherapy.2025: Several states, including Oregon and Colorado, legalized psilocybin for therapeutic use, creating a nascent market valued at roughly $2 billion.Potential Shift in Federal Drug PolicyTrump’s backing could influence congressional committees that oversee the Drug Enforcement Administration and the FDA. A high‑profile endorsement may:Accelerate bipartisan bills aimed at de‑scheduling certain psychedelics.Encourage the administration to prioritize research funding in upcoming budget proposals.Prompt the White House to convene a task force on psychedelic medicine.Impact on Mental‑Health Treatment ParadigmsShould policy changes follow, clinicians could gain broader access to psychedelic‑assisted therapies, potentially reducing reliance on traditional antidepressants. This aligns with growing evidence that psychedelics can produce rapid, sustained improvements for conditions such as PTSD and major depressive disorder.Looking Ahead: Political and Clinical OutlookAnalysts anticipate that Trump’s endorsement will keep psychedelics on the national agenda through the 2026 midterm elections. If legislative momentum continues, the United States could see:A federal framework for clinical trials by 2027.Expanded insurance coverage for approved psychedelic treatments by 2028.Increased private‑sector investment, potentially adding $5 billion to the market over the next five years.

The LeadResearchers at Imperial College London have shown that a single 25 mg dose of psilocybin can produce detectable anatomical changes in the brain that persist for at least a month, offering fresh clues about how psychedelics may alleviate mental‑health disorders.Single Dose of Psilocybin Triggers Measurable Brain Structure Changes28 healthy volunteers with no prior psychedelic experience participated.Participants received a low “placebo” dose (1 mg) followed, a month later, by a full psychedelic dose (25 mg).Brain activity was monitored with EEG, functional MRI, and diffusion tensor imaging (DTI).Diffusion Tensor Imaging Reveals Reduced Nerve Tract DiffusionOne month after the psychedelic dose, DTI scans showed a drop in water diffusion along front‑to‑mid‑brain nerve tracts, suggesting either pruning of existing fibres or growth of new, unmyelinated connections. The same participants also exhibited a surge in EEG‑measured brain entropy within an hour of dosing.Potential Ripple Effects on Psychedelic TherapeuticsThe anatomical shift mirrors patterns seen in ageing and dementia—where diffusion typically increases—hinting that psilocybin may promote a rejuvenating “entropic brain” state. Researchers linked the magnitude of entropy spikes to deeper psychological insight and improved wellbeing, reinforcing the hypothesis that structural plasticity underlies therapeutic outcomes. Senior author Robin Carhart-Harris described the result as “remarkable”.What This Means for Future Psychedelic Research and TreatmentLarger, longitudinal studies are needed to confirm durability of the changes.If replicated, DTI could become a biomarker for assessing psychedelic efficacy.The findings may accelerate clinical trials targeting depression, anxiety, and addiction.While promising, the study’s small sample size and indirect imaging methods warrant caution, but the evidence moves the field closer to a mechanistic understanding of psychedelic‑induced neuroplasticity.

The Rise of 'Quantum-Inspired' Enterprise AI in EuropeQuTwo, the Helsinki-based AI lab founded by former AMD Silo AI CEO Peter Sarlin, has secured a $29 million angel round, valuing the company at $380 million. This funding marks a pivotal moment for European sovereign tech, highlighting a strategic pivot away from hyper-growth VC models toward long-term R&D; in 'quantum-inspired' computing.Orchestrating the Hybrid FutureQuTwo's core offering, QuTwo OS, is an orchestration layer designed to direct tasks across classical, quantum, and hybrid architectures. Rather than betting solely on the nascent quantum hardware market, Sarlin argues that enterprise use cases are best served by 'quantum-inspired' computing—using classical chips to simulate quantum behavior. This approach allows for more reliable hardware deployment while preparing for the eventual quantum era.Product Focus: QuTwo OS directs tasks to classical, quantum, or hybrid architectures.Core Philosophy: 'Quantum-inspired' computing uses classical chips to simulate quantum behavior.Enterprise Goal: To serve bread-and-butter business needs with reliable hardware.A Strategic Valuation in a Billion-Dollar EraWhile the $380 million valuation is significant, it is notably 'modest' compared to the $1 billion+ rounds seen in the European AI space recently (e.g., Ineffable Intelligence, Ami Labs). By choosing an angel round over a massive VC injection, QuTwo avoids the pressure to become Europe's 'OpenAI' immediately. Instead, the company leverages a network of high-profile investors like Yuri Milner and Xavier Niel to facilitate introductions and strategic partnerships rather than just capital.Europe's Sovereign Tech MomentumThe funding comes at a critical geopolitical time. As Europe seeks to reduce reliance on U.S. tech providers, there is a strong tailwind for local alternatives. QuTwo's expansion into Sweden and hiring of 50 scientists signals a commitment to building a regional powerhouse in automotive, life sciences, and gaming sectors. This move aligns with a broader trend of European founders prioritizing long-term mission over short-term exit strategies.The Long-Term Horizon for AI and QuantumSarlin’s strategy suggests that the next decade will be defined by the integration of classical and quantum computing paradigms. By focusing on the 'next paradigm' rather than the current one, QuTwo aims to position itself as a global leader. The success of this model will likely encourage other European founders to follow suit, favoring sustainable, mission-driven growth over aggressive scaling.

The Executive Order That Changed Psychedelic PolicyIn a surprising move during the weekend celebrating 'Bicycle Day' – the anniversary of the first LSD trip – Donald Trump signed a landmark executive order to accelerate research into hallucinogens and increase access to them. The scene was surreal as Trump joked, 'Can I have some, please?' when discussing ibogaine, a lesser-known psychedelic known for its 12-hour trips that often provide visions of traumatic personal memories.Accelerated FDA Review ProcessThanks to the order, the US Food and Drug Administration (FDA) will fast-track the reviews of three incoming psychedelic drug candidate applications that have already received breakthrough therapy designations. These are likely to be psilocybin for two types of depression and MDMA for PTSD, a prior application for which was rejected by the FDA in 2024. This move represents the biggest greenlight the potential multibillion-dollar market has yet received, causing psychedelic company stocks to soar.Financial Implications of the Psychedelic MarketThe executive order has significant financial implications for the emerging psychedelic industry. Industry analyst Josh Hardman noted that the expected issuance of these vouchers shows just how much the White House has changed its mind on psychedelics in the last six months. The Department of Health and Human Services also announced a new $139m initiative to help spur new, effective therapies for behavioral health, including the safe use of psychedelics, with at least $50m earmarked to match state psychedelic research initiatives.Industry and Regulatory TransformationThis executive order marks a significant shift in the approach to psychedelic substances in the United States, which have been federally illegal since Richard Nixon passed the 1970 Controlled Substances Act. The order states that investigational psychedelic drugs will become available under 'right to try' legislation, which is typically reserved for terminally ill patients and those who have tried all approved treatment options. However, this sets up a potential clash with the Drug Enforcement Administration (DEA), which has previously stated that schedule I compounds are ineligible for right to try.Future Outlook for Psychedelic MedicineThe future of psychedelic medicine in the US appears to be accelerating, but with significant challenges remaining. While Trump indicated his administration is already working on rescheduling efforts, which would require approval from the DEA, concerns remain about pharmaceutical and commercial interests being the primary beneficiaries of the order. Indigenous communities that have stewarded psychedelics like ibogaine and psilocybin worry they won't be fairly compensated for their knowledge. As psychedelic reform advocate Ismail Ali noted, 'It is a substantial threshold moment,' but 'if you're looking at the US federal government for the full liberation of these plants, you're probably looking in the wrong place.' The coming years will determine whether this marks the beginning of a truly accessible psychedelic medicine future or another chapter in extraction and commercialization.